Skip to main content
Fig. 3 | Clinical Epigenetics

Fig. 3

From: HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma

Fig. 3

The performance of HepaClear in the training and validation sets. A, B ROC curves of the HepaClear panel compared with AFP and DCP alone in the training group among all-stage patients (A) and early-stage HCC patients (B). C, D Predicted score distributions among healthy controls, CHB, LC and HCC patients in the training group (C) and the validation group (D)

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us